WallStreetZenWallStreetZen

NASDAQ: EXEL
Exelixis Inc Stock Ownership - Who owns Exelixis?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Exelixis Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Dana AftabEVP Research and Development2026-02-2447,918$44.50
$2.13MSell
Dana AftabEVP Research and Development2026-02-1929,873$44.35
$1.32MSell
Jack L. WyszomierskiDirector2026-02-1820,634$19.77
$407.93kBuy
Julie SmithDirector2026-02-1820,030$44.30
$887.33kSell
Jack L. WyszomierskiDirector2026-02-1899,574$44.01
$4.38MSell
Julie SmithDirector2026-02-1844,087$19.39
$854.85kBuy
Julie SmithDirector2026-02-1844,087$44.50
$1.96MSell
Julie SmithDirector2026-02-1820,030$21.69
$434.45kBuy
Brenda HeftiSVP and General Counsel2026-02-1818,669$44.01
$821.62kSell
Patrick J. HaleyEVP Commercial2026-02-1764,778$43.50
$2.82MSell

1 of 7

EXEL insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when EXEL insiders and whales buy or sell their stock.

EXEL Shareholders

What type of owners hold Exelixis Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc11.63%30,201,862$1.25BInstitution
Vanguard Group Inc9.82%25,490,449$1.05BInstitution
Farallon Capital Management LLC6.05%15,709,500$647.86MInstitution
Renaissance Technologies LLC5.36%13,914,043$573.82MInstitution
Aqr Capital Management LLC5.26%13,658,388$563.27MInstitution
State Street Corp4.04%10,491,342$432.66MInstitution
Fuller Thaler Asset Management Inc3.07%7,960,896$328.31MInstitution
Lsv Asset Management2.98%7,745,932$319.44MInstitution
Geode Capital Management LLC2.90%7,529,163$310.50MInstitution
Invesco Ltd2.33%6,054,743$249.70MInstitution

1 of 3

EXEL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
EXEL94.72%5.28%Net SellingNet Selling
BMRN97.84%1.74%Net SellingNet Selling
JAZZ28.78%71.22%Net SellingNet Selling
MDGL26.15%73.85%Net BuyingNet Selling
IONS96.84%3.16%Net SellingNet Selling
View Top Biotech Stocks

Exelixis Stock Ownership FAQ

Who owns Exelixis?

Exelixis (NASDAQ: EXEL) is owned by 100.23% institutional shareholders, 5.59% Exelixis insiders, and 0.00% retail investors. Michael Morrissey is the largest individual Exelixis shareholder, owning 3.65M shares representing 1.40% of the company. Michael Morrissey's Exelixis shares are currently valued at $149.76M.

If you're new to stock investing, here's how to buy Exelixis stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.